Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-26 | Cheryl L. Cohen was nominated for election to our Board of Directors in March 2022. Since 2008, Ms. Cohen has served as President of CLC Consulting, a pharmaceutical and biotechnology consulting firm that specializes in new product start-ups and commercialization. ... Ms. Cohen currently serves on the board of directors of MEI Pharma, Immunity Bio (previously NantKwest) and Ignyte Acquisition Corp., all of which are publicly traded companies. |
| 2023-04-25 | Cheryl L. Cohen 57 2022 2 The Board of Directors has established a Compensation and Organization Development Committee currently consisting of James J. Marino, Chair, Cheryl L. Cohen and Harry H. Penner, Jr. The Board of Directors has established a Nominating and Corporate Governance Committee currently consisting of Herbert J. Conrad, Chair, Cheryl L. Cohen and Garry Neil, M.D. The following table summarizes the annual compensation for our non-employee directors during 2022. Cheryl L. Cohen Fees Earned or Paid in Cash ($) 39,505 Option Awards ($) 463,733 Total ($) 503,238 |
| 2024-04-25 | The Board of Directors has established a Compensation and Organization Development Committee currently consisting of James J. Marino, Chair, Cheryl L. Cohen and Harry H. Penner, Jr. ... The Compensation and Organization Development Committee met six times during 2023. ... The Board of Directors has established a Science and Regulatory Committee currently consisting of Garry Neil, M.D., Chair, Cheryl L. Cohen and Rita Jain, M.D. ... The amounts in the Option Awards column reflect the grant date fair value in accordance with U.S. GAAP of stock option awards made in 2023 to each of our non-employee directors for awards pursuant to the 2021 Incentive Plan subject to a vesting schedule whereby an equal number of the shares of common stock shall become vested and no longer be subject to risk of forfeiture (so long as the director remains a member of the Board as of such date). |
| Filing Date | Source Excerpt |
|---|---|
| 2015-10-07 | Ms. Cohen received her B.A. from Saint Joseph College. |
| 2016-04-14 | Ms. Cohen received her B.A. from Saint Joseph College. We believe that Ms. Cohen is qualified to serve on our board of directors based on her experience as an executive officer and director of private and publicly-traded companies, including companies in the pharmaceutical and bio-pharmaceutical industries. |
| 2017-04-11 | Ms. Cohen received her B.A. from Saint Joseph College. We believe that Ms. Cohen is qualified to serve on our board of directors based on her experience as an executive officer and director of private and publicly-traded companies, including companies in the pharmaceutical and bio-pharmaceutical industries. |
| 2018-04-12 | Ms. Cohen received her B.A. from Saint Joseph College. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-24 | We believe that Ms. Cohen is qualified to serve as a member of our board of directors because of her extensive experience and knowledge in the healthcare industry and experience serving on boards of directors of public companies. |
| 2021-04-29 | Ms. Cohen has served as President of CLC Consulting, a pharmaceutical and biotechnology consulting firm specializing in new product start-up and commercialization, since 2008. Ms. Cohen received her B.A. from Saint Joseph College. We believe that Ms. Cohen is qualified to serve as a member of our board of directors because of her extensive experience and knowledge in the healthcare industry and experience serving on boards of directors of public companies. |
| 2022-04-29 | Ms. Cohen received her B.A. from Saint Joseph College. We believe Ms. Cohen is qualified to serve as a member of the Board based on her extensive experience with and knowledge of the healthcare industry, commercialization expertise, and experience serving on boards of directors of public companies. |
| 2023-04-28 | Ms. Cohen has served as principal owner and president of CLC Consulting, LLC, a pharmaceutical and biotechnology consulting firm specializing in new product start-up and commercialization. She has a B.A. from Saint Joseph College. |
| 2024-04-29 | Ms. Cohen has served as principal owner and president of CLC Consulting, LLC, a pharmaceutical and biotechnology consulting firm specializing in new product start-up and commercialization. Prior to CLC, she served as chief commercial officer of Medivation, Inc., a publicly-traded bio-pharmaceutical company. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-10-27 | She earned a B. A. degree from Saint Joseph College. |
| 2021-10-28 | Ms. Cohen earned a B. A. degree from Saint Joseph College. She has more than 25 years of leadership experience within the pharmaceutical and biotechnology industries, including roles in commercialization and consulting. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22